Histopathological analysis of sentinel lymph node in breast cancer. The experience of Institut Gustave-Roussy;Analyse histopathologique du ganglion sentinelle dans le cancer du sein: Expérience de l'Institut Gustave-Roussy

Annales de Pathologie

Volumn 23, Issue 6, 2003, Pages 508-517

  Mathieu, Marie Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Breast cancer; Immunohistochemistry; Sentinel lymph node

Indexed keywords

ACCURACY; AXILLARY LYMPH NODE; BREAST CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PATIENT SELECTION; REVIEW; SENTINEL LYMPH NODE; TECHNIQUE;

ACADEMIES AND INSTITUTES; AXILLA; BREAST NEOPLASMS; FEMALE; FRANCE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 1842575910     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-66.
2. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
3. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993; 2: 137-43.
4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-8.
5. Travagli JP, Atallah D, Mathieu MC, Rochard F, Camatte S, Lumbroso J et al. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 2003; 29: 403-6.
6. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18: 2560-6.
7. Ricard M, Bard JJ, Boneu L. Radioprotection et détection peropératoire du ganglion sentinelle par colloïde marqué au technétium. Med Nucl 1998; 22: 431-4.
8. Fitzgibbons PL, LiVolsi VA. Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy. Surgical Pathology Committee of the College of American Pathologists, and the Association of Directors of Anatomic and Surgical Pathology. Am J Surg Pathol 2000; 24: 1549-51.
9. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39: 1654-67.
10. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR et al. Sentinel-lymph-node biopsy for breast cancer-not yet the standard of care. N Engl J Med 1998; 339: 990-5.
11. ANAES. La technique du ganglion sentinelle dans le cancer du sein. Octobre 2002.
12. Kane JM, III, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 2001; 8: 361-7.
13. Smidt ML, Besseling R, Wauters CA, Strobbe LJ. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. Br J Surg 2002; 89: 1290-3.
14. Creager AJ, Geisinger KR. Intraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies. Adv Anat Pathol 2002; 9: 233-43.
15. Chao C, Wong SL, Ackermann D, Simpson D, Carter MB, Brown CM et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 2001; 182: 609-15.
16. Turner RR, Hansen NM, Stern SL, Giuliano AE. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 1999; 112: 627-34.
17. Viale G, Bosari S, Mazzarol G, Galimberti V, Luini A, Veronesi P et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999; 85: 2433-8.
18. Zurrida S, Mazzarol G, Galimberti V, Renne G, Bassi F, Lafrate F et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol 2001; 8: 817-20.
19. ADASP recommendations for processing and reporting lymph node specimens submitted for evaluation of metastatic disease. Am J Surg Pathol 2001; 25: 961-3.
20. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 966-78.
21. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002; 94: 2542-51.
22. Turner RR, Giuliano AE, Hoon DS, Glass EC, Krasne DL. Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 2001; 25: 798-805.
23. de Mascarel I, Mac Grogan G. Stratégies pour la prise en charge des ganglions axillaires dans les cancers du sein. Ann Pathol 2003; 23: 517-32.
24. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001; 42: 1198-215.
25. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC Jr. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Cancer 1999; 86: 990-6.
26. Canavese G, Gipponi M, Catturich A, Di Somma C, Vecchio C, Rosato F et al. Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol 1998; 15: 272-7.
27. Mathieu MC, Suciu V, Garbay JR, Lumbroso J, Travagli JP. Isolated tumor cells in the sentinel node and risk of axillary non sentinel node involvement in patients with breast carcinomas. Abstract 169. Congress of USCAP. Washington, March 2003.
28. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997; 3: 336-40.
29. Farshid G, Pradhan M, Kollias J, Gill PG. Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma. Cancer 2000; 89: 2527-37.
30. Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 1998; 69: 212-8.
31. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002; 55: 926-31.
32. Garbay JR, Guinebretiere JM, Mathieu MC, Rochard F. Le ganglion sentinelle dans le cancer du sein. Est-ce la fin du curage dans les petites tumeurs NO ? Gynecol Obstet Fertil 2002; 30: 514-22.
33. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-73.
34. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36.
35. Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg 2002; 89: 1505-15.
36. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001; 92: 1378-84.
37. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003; 10: 248-54.
38. Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 2002; 183: 213-7.
39. Chen M, Palleschi S, Khoynezhad A, Gecelter G, Marini CP, Simms HH. Role of primary breast cancer characteristics in predicting positive sentinel lymph node biopsy results: a multivariate analysis. Arch Surg 2002; 137: 606-9.
40. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Woo C et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 2001; 136: 563-8.
41. Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001; 8: 145-9.
42. Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 2002; 28: 623-6.
43. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 2002; 184: 302-6.
44. Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku Nn et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla - A study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001; 136: 688-92.
45. Freneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, Al Ghuzlan A et al. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 2002; 15: 641-6.
46. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-50.